Literature DB >> 17227984

Adjuvant therapy for pancreatic cancer: one small step forward.

Al B Benson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17227984     DOI： 10.1001/jama.297.3.311

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Diagnostic utility of clinical and biochemical parameters in pancreatic head malignancy patients with normal carbohydrate antigen 19-9 levels.

Authors:  Xiaoli Jin; Yulian Wu
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.

Authors:  Mao-Song Lin; Wei-Chang Chen; Jun-Xing Huang; Heng-Jun Gao; Hai-Hui Sheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Authors:  William F Regine; Kathryn A Winter; Ross Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Ann Surg Oncol       Date:  2011-03-10       Impact factor: 5.344

4.  Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.

Authors:  Jiangning Gu; Di Wang; Ya Huang; Yi Lu; Chenghong Peng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 5.  Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

Authors:  S Bünger; T Laubert; U J Roblick; J K Habermann
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-31       Impact factor: 4.553

6.  Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score.

Authors:  Sinziana Dumitra; Mohammad H Jamal; Jad Aboukhalil; Suhail A Doi; Prosanto Chaudhury; Mazen Hassanain; Peter P Metrakos; Jeffrey S Barkun
Journal:  HPB (Oxford)       Date:  2013-03-22       Impact factor: 3.647

7.  A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

Authors:  Andrew J Lepisto; Arthur J Moser; Herbert Zeh; Kenneth Lee; David Bartlett; John R McKolanis; Brian A Geller; Amy Schmotzer; Douglas P Potter; Theresa Whiteside; Olivera J Finn; Ramesh K Ramanathan
Journal:  Cancer Ther       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.